However, differently from our findings, CCN2 targeting with FG-3019 did not cause alterations in the tumor microenvironment, suggesting possible differences in the mechanisms of CCN2 inhibition between the antibody and the BLR peptides. Here, CCN2 is linked to neoplasm.